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Myeloid differentiation proteins MD-1 and MD-2 have both been shown to form a heterogeneous collec-
tion of oligomers when expressed in absence of their respective receptor, RP105 and TLR4. The biological
relevance of these oligomers is not clear. Only monomeric proteins have been found to be active and able
to trigger an immune response to endotoxin by modulating the TLR4 pathway. In this study, we produced
variants of MD-1 and MD-2 in Pichia pastoris. To minimize the time and expense of initial expression tests,
small-scale cultures have been set up to allow the rapid identiﬁcation of the highest expressing clone and
the optimal expression conditions. The expression vectors used, the site of linearization and the locus of
integration affected the yield of transformation. Next we screened culture additives and found that they
signiﬁcantly increased the fraction of monomeric proteins secreted in the culture medium (up to 15% of
the total MD protein produced). We conﬁrmed their presence by size-exclusion chromatography. Optimal
anti-aggregation agents were protein-dependent except for LPS that presented stabilizing effects for all
MD proteins. Contrary to previous reports, this study suggests that MD-1 can bind to LPS.
 2010 Elsevier Inc. Open access under CC BY license.Introduction
Myeloid differentiation proteins MD-1 and MD-2 are disulﬁde-
rich glycoproteins of 20–25 kDa, tethered to the cell surface by
type 1 immune receptors radioprotective protein RP105 and Toll-
like receptor TLR4, respectively [1]. Lipopolysaccharide (LPS)1 shed
by Gram-negative bacteria is recognized by MD-2, which contains
the main if not the only binding site amongst all four proteins. LPS
binding to MD-2 triggers an immune response by changing the qua-
ternary structure of the TLR4–MD-2 receptor complex [2,3]. Signal
transduction is then mediated by TLR4 and ultimately activates over
a thousand genes to ﬁght the microbial infection [4,5]. MD-1 is a dis-
tant homologue of MD-2 (18% identity) and RP105 has structural
similarities to TLR4. Although RP105 conserves the extracellular
leucine-rich repeats (LRRs), to which MD-1 binds, it lacks the
intracellular signaling domain (the Toll-Interleukin-1 Receptor TIR
domain) and contains instead a short cytoplasmic tail. The physio-
logical roles of MD-1 and RP105 are not clear. A host of controversialiochemistry, 80 Tennis Court
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 license.ﬁndings suggest either positive or negative regulation capacities of
MD-1 and RP105 on TLR4 signalling [6,7]. In a recent study, evidence
has been presented that MD-1-RP105 cannot bind LPS in contrast to
MD-2-TLR4 and that these proteins are sequestered in an inactive
tetrameric complex in which MD-1 and MD-2 interact [8].
The structural and functional characterization of MD-1 and
MD-2 proteins (MD proteins) has been delayed by the difﬁculties
in producing active monomeric proteins. Indeed, MD proteins tend
to aggregate in unstructured multimers containing intermolecular
disulﬁdes instead of intramolecular ones [9–11]. However, human
MD-2 (hMD-2) has successfully been expressed in Pichia pastoris,
puriﬁed, crystallized and its crystal structure solved in two com-
plexed forms [11]. The ﬁrst was obtained without added ligand
and the determination of the structure revealed the presence of
fatty acid molecules in the hydrophobic ligand-binding cavity.
The second form was obtained by addition of lipid IVa, a substruc-
ture of LPS, which is inactive in human. Another group coexpressed
human and mouse variants of MD-2 and TLR4 in a baculovirus
expression system and successfully determined their atomic struc-
tures [2,12].
In previous work, we and others have found that lipid IVa dis-
played species-speciﬁc activities. Although inactive in human, lipid
IVa is an agonist in mouse and horse [13–16]. We then established
which residues were responsible for lipid IVa activity by generat-
ing chimeric forms of human and horse TLR4 and MD-2 proteins.
In the course of this study, we characterized a chimera of MD-2
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into the human protein. Interestingly, HE82–89 displayed a signif-
icant level of constitutive activity suggesting that the area of inter-
est was involved in the ligand-induced conformational change
[16]. Here, we pursue the study of this chimera, as well as horse
MD-2 (eMD-2) and human MD-1 (hMD-1) using the P. pastoris
expression system and hMD-2 as a positive control. In standard
conditions, we found that expression failed to produce detectable
amounts of monomeric proteins. We then decided to screen con-
structs, yeast strains, recombinant colonies, culture medium,
induction conditions and additives in order to increase the fraction
of monomers. We found that the presence of a range of protein-
speciﬁc additives in the culture medium during induction and
along puriﬁcation was a good strategy to decrease the propensity
of these proteins to aggregate via intercatenary disulﬁde bonding.0
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Fig. 1. Optimal plasmid fragments for Pichia transformation. Several combinations
of linearized plasmids were transformed into Pichia strain GS115. pPIC9K linearized
at its 50AOX1 (with SacI and PmeI) or HIS4 locus (with SalI) were transformed, along
with pPICZa linearized at its 50AOX1 locus (with SacI). Transformation reaction 1:
pPIC9K blunt ends at 50AOX1 with PmeI; reaction 2: pPIC9K sticky ends at 50AOX1
with SacI; reaction 3: pPICZa sticky ends at 50AOX1 with SacI; reaction 4: double
selection with pPIC9K sticky ends at HIS4with SalI and pPICZa sticky ends at 50AOX1
with SacI; reaction 5: triple selection with pPIC9K sticky ends at HIS4 with SalI and
both pPIC9K and pPICZa with sticky ends at their respective 50AOX1 loci with SacI.
The number of antibiotic-resistant colonies isolated after transformation of each
combination of linearized plasmids was recorded.Material and methods
Construct design
The coding sequences for mature hMD-2, eMD-2, HE82–89, and
hMD-1 without their N-terminal signal sequences were cloned into
the Pichia expression plasmids pPIC9K and pPICZa (Invitrogen).
Primers for each construct were designed to incorporate an N-ter-
minal EcoRI restriction site, His6-tag, and TEV cleavage site up-
stream of the gene of interest, followed by a C-terminal stop
sequence and NotI restriction site. Both pPIC9K and pPICZa con-
structs allow secretion of MD-1 and MD-2 variants, as they contain
the secretion signal sequence from the Saccharomyces cerevisiae
a factor prepro peptide upstream of the multiple cloning site.
P. pastoris strains
GS115 (his4 genotype; Mut+, His phenotype) and KM71H (arg4
aox1::ARG4 genotype; MutS, His+, Arg+ phenotype) P. pastoris cells
were used for screening protein expression in different back-
grounds of histidine auxotrophy and alcohol oxidase activity.
Mut+ stands for methanol-utilization-fast; MutS, methanol-utiliza-
tion-slow, which is the phenotype of cells lacking the AOX1 gene.
His phenotype is caused by a his4mutation introduced in the his-
tidinol dehydrogenase gene, which prevents the cells from synthe-
sizing histidine. GS115 was therefore grown on complex medium
or on minimal medium supplemented with histidine. His+ pheno-
type was restored in GS115 upon pPIC9K but not pPICZa transfor-
mation. Growth on minimal medium in absence of histidine was
used as a selectable marker to isolate recombinant colonies upon
pPIC9K. KM71H has an intact HIS4 gene but an arg4 mutation in
the argininosuccinate lyase gene and a wild-type ARG4 gene
replacing the AOX1 gene resulting in a MutS, Arg+ strain.
Generation of recombinant P. pastoris strains
GS115 and KM71H cells were maintained and transformed
according to the Pichia expression kit manuals (Invitrogen
K1710-01, K1740-01 and K1750-01). The composition of the
different Pichia culture media used in this study is described in
Supplementary Table 1. Brieﬂy, cultures were grown in a complex
medium of YPD (Yeast extract Peptone Dextrose) to an OD600nm of
1.3–1.5. Cells were harvested and washed in ice-cold sterile water
twice before resuspension in 1 ml ice-cold 1 M sorbitol. All con-
structs were linearized prior to transformation. The empty host
vectors pPIC9K and pPICZh were prepared for transformation in
parallel, for use as a negative control for MD-1 and MD-2 expres-
sion. pPIC9K constructs were linearized by digestion with either
SacI, PmeI, or SalI (New England Biolabs). pPICZh constructs werelinearized by digestion with SacI or PmeI. Digestions were per-
formed for 3 h at 37 C, and complete linearization was veriﬁed
by agarose gel electrophoresis. Following linearization, construct
DNA was puriﬁed by ethanol precipitation and redissolved in
5–10 lL sterile water. Eighty microliters of electrocompetent cells
were gently combined with 20 lL DNA. The amount of DNA per
transformation was 20 lg for a single DNA preparation (Fig. 1a,
reaction number 1, 2 and 3) or 10 lg of each preparation with a
mixture of DNAs (Fig. 1a, reaction number 4 and 5). After pulsing
at 1.5 kV, 25 lF, 200X, 1 ml of ice-cold sorbitol was added to the
electroporation cuvette (Cell Projects). Aliquots of this suspension
were spread on minimal dextrose (MD) and Regeneration Dextrose
Base (RDB) medium plates for pPIC9K transformants and on YPDS
plates containing 100 lg/ml Zeocin™ for pPICZa transformants.
Colonies grew within 5 days at 30 C. pPIC9K colonies were subse-
quently screened on YPD plates in the presence of increasing con-
centrations of Geneticin (between 0.25 and 10.0 mg/ml). Frozen
stocks of all colonies growing on either Zeocin™-containing plates
or exhibiting resistance to 10 mg/ml Geneticin were prepared for
backup and used in expression trials.
Determination of the methanol-utilization phenotype
The methanol-utilization phenotype of antibiotic-resistant
GS115 colonies was veriﬁed, as there is a small probability that
recombination with the Pichia genome can disrupt the AOX1 locus.
Each colony was individually picked and streaked on a minimal
methanol (MM) plate and a minimal dextrose (MD) plate in a reg-
ular pattern in the presence of histidine as required (for pPICZa
transformants). Untransformed Pichia strains were also plated to
serve as controls for the MutP+P and MutPsP phenotype, respec-
tively. After incubation at 30 C for 2 days, the plates were scored
for growth by counting the number of colonies per plate.
Recombinant protein production
A single colony was used to inoculate 5 ml YPD starter culture,
and grown overnight shaking at 30 C (225 rpm). This subculture
was used to inoculate cultures either in minimal glycerol (MGY),
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(BMGY) medium. At an OD600nm of 2–6, the cells were harvested
by centrifugation at 1500–3000g for 5–10 min at room temperature
and resuspended to an OD600nm of 1.0 in minimal methanol (MM),
buffered minimal methanol (BMM), or buffered methanol-complex
(BMMY) medium to induce expression. The culture medium was
combined in a sterile manner with additives ﬁltered on 0.2 lm PES
membrane when required. Methanol was added every 12–24 h to
a ﬁnal concentration of 0.5–2% tomaintain induction. Cultureswere
carriedouteither in24-wellplates (with2 mlperwell), in50 mlcon-
ical tubes (with 5 ml culture) placed at a 45 angle, 250 ml bafﬂed
ﬂasks (with 25 ml culture) or in 2 L bafﬂed ﬂasks (with 200 ml cul-
ture) covered in 3 layers of sterilemuslin gauze for optimal aeration.
Aliquotswere takendaily over amaximumperiodof 6 days to deter-
mine recombinant protein production by dot blot analysis and by
SDS–PAGE andWestern blotting on culture supernatants.
Puriﬁcation of secreted MD proteins
Recombinant His-tagged proteinswere puriﬁed from the culture
medium by metal afﬁnity chromatography on a 5 ml Chelating Hi-
Trap (GE Healthcare Life Sciences) after preﬁltration on Sartoban P
ﬁlters (Sartorius) and buffer-exchange of the culture supernatant
by tangential ﬂow ﬁltration (Pall Corporation). These extra steps
were required to dilute the ingredients in the culture medium that
would strip the metal ions off the afﬁnity column. Akta FPLC (Phar-
macia) was used to elute the protein from the nickel column, in
either gradient or step elution. The optimal elution scheme was
found to be a step elution from Buffer A (50 mM Tris–HCl, 5 mM
imidazole, pH 7.0) to Buffer B (50 mM sodium acetate, pH 3.5) in
the presence of the appropriate anti-aggregation additive. Further
puriﬁcation was carried out using size-exclusion chromatography
on HiLoad 16/60 Superdex 200 prep grade gel-ﬁltration columns
(GE Healthcare Life Sciences) in 50 mM sodium acetate, pH 5.0, also
in thepresenceof theappropriateanti-aggregationadditive. Puriﬁed
proteins were analyzed by SDS–PAGE, Western and dot blotting.
Western and dot blot analysis
Protein samples were separated by SDS–PAGE for Western
blotting. Electroblotting to Hybond-C nitrocellulose membrane
(Amersham Biosciences) was performed at 100 V for 45 min in
Tris–Glycine transfer buffer. The membrane was reversibly stained
with Ponceau S (Sigma) to ensure complete protein transfer. For
dot blot analysis, 5 ll of each protein sample was added directly
to Hybond-C nitrocellulose membrane (GE Healthcare Life Sci-
ences), and allowed to dry completely. Membranes were blocked
overnight at 4 C in PBS, 0.05% Tween, 3% milk solution. After incu-
bation with shaking for 1 h with primary anti-His antibody (BD
Biosciences) at a dilution of 1:2500 in PBS-Tween-milk solution,
membranes were washed three times for 15 min in PBS, 0.05%
Tween. They were then incubated with shaking for 1 h with sec-
ondary HRP-conjugated-anti-mouse antibody (Sigma) at a dilution
of 1:3000 in PBS-Tween-milk solution, and washed three times for
15 min in PBS-Tween. Chemoluminescent ECL substrate (Thermo
Scientiﬁc) was added to the membrane, which was then exposed
to X-ray ﬁlm for 1 min for development.Results
The expression vector, the site of linearization and the locus of integra-
tion used affect the yield of P. pastoris transformation
Human (hMD-2), equine (eMD-2) and a chimera of human MD-
2, in which residues 82–89 where substituted with the equivalentequine sequence (HE82–89), as well as human MD-1 (hMD-1)
were cloned downstream of an N-terminal His6-tag and a TEV
cleavage site into the P. pastoris expression vectors pPIC9K and
pPICZa Invitrogen to yield 8 constructs for yeast transformation.
Before transformation, each construct was linearized by restriction
enzyme digestion in order to stimulate recombination with the
Pichia genome. The plasmids contain numerous suitable restriction
sites at the 50AOX1 locus for both pPIC9K and pPICZa and at the
HIS4 locus for pPIC9K. To our knowledge, there was no previous
study that had compared the efﬁciency of transformation of a given
gene using (i) two expression vectors (ii) linearized at different
sites (iii) for recombination at different loci (iv) transformed inde-
pendently or (v) simultaneously. We therefore performed multiple
reactions on one of the genes of interest (hMD-1) to check whether
these parameters would affect the yield of transformation.
Recombinant pPIC9K was linearized at either the 50AOX1 site
with SacI or PmeI or the HIS4 locus with SalI. Recombinant pPICZa
was cleaved at the 50AOX1 locus with SacI. SacI and SalI generate
sticky-ended fragments upon digestion, while PmeI generates
blunt-ended fragments, which might inﬂuence the rate of recombi-
nation. Several combinations of these linearized fragments were
transformed into Pichia strain GS115, and the number of transfor-
mants isolated after each transformation was recorded (Fig. 1).
Histidine prototrophy followed by Geneticin-resistance were
used for selecting pPIC9K transformants in absence and in the
presence of pPICZawhereas Zeocin™-resistance allowed the selec-
tion of pPICZa transformants.
Contrary to expectations the combined use of expression vec-
tors did not improve the yield of transformation regardless of the
site of integration (at the AOX1 and the HIS4 loci). Transformation
of blunt-ended pPIC9K (PmeI-restricted) yielded almost twice as
many colonies as transformation of sticky-ended pPIC9K plasmid
(SacI-digested). This is expected considering the length of the
homologous regions available for recombination, which is only
208 bp on the 50 side of AOX1 of the SacI cleavage site in compari-
son to 413 bp for PmeI out of a possible 942 bp at the 50AOX1 pro-
moter. Given these variations in size, we cannot conclude on the
inﬂuence of blunt versus sticky-end DNA overhangs in the efﬁ-
ciency of recombination. In our hands, recombination seemed to
be more dependent on fragment length than on the nature of the
DNA ends at the 50AOX1 locus.
Furthermore we noticed that transformation with pPICZa
yielded 70% fewer colonies than pPIC9K when both plasmids were
linearized at the SacI site of 50AOX1. Also pPIC9K recombination at
the AOX1 site appeared to be favored compared to the HIS4 locus
according to the number of antibiotic-resistant colonies after
transformation. This effect cannot be explained by the length of
the homologous regions, which are 1199 bp at HIS4 linearized by
SalI (out of a total of 2535 bp) but is most likely a locus-dependent
effect.
The phenotypic background affects protein expression
By using pPIC9K and pPICZa vectors in GS115 and in KM71H
strains, three different phenotypic backgrounds can be generated
assuming that gene replacement does not occur. Upon transforma-
tion of GS115 (Mut+, His) with pPIC9K the recombinant strain is
Mut+, His+ whereas the use of pPICZa retains the Mut+, His pheno-
type and thus requires minimal medium to be supplemented with
histidine. Transformation of KM71H (MutS, His+) stays MutS
regardless of the expression vector used. We have not used the
wild type strain X33 (Mut+, His+) in this study as we can explore
the same phenotype using GS115 and pPIC9K.
The methanol-utilization phenotype of GS115 colonies was ver-
iﬁed (see Material and methods), as there is a small probability
that recombination with the Pichia genome can disrupt the AOX1
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MutP+ phenotype according to their growth rate on minimum
methanol (MM) compared to minimum dextrose (MD) plates.
Screening for the methanol-utilization phenotype of KM71H colo-
nies was not performed as the AOX1 locus is inherently disrupted
in this strain, and cannot be restored through recombination.
As different phenotypes can have different advantages for pro-
tein expression we have compared the expression levels of hMD-
1 produced in a His+ background such as the one obtained by using
GS115–pPIC9K strains and in the His- background of GS115–pPIC-
Za (Fig. 2). 48 colonies isolated after transformation reaction 1 and
3 were selected for small-scale expression trials, and the relative
expression levels were assessed by dot blot analysis of 5 ll culture
supernatants. The signal given by each dot was quantiﬁed using
the image-processing program, ImageJ and compared in Fig. 2.
We found that only about 30% of the His GS115–pPICZa strains
provided detectable protein expression in contrast to all 48 His+
pPIC9K transformants tested. It is not entirely clear if this is solely
due to the phenotype. We cannot rule out that the double selection
of pPIC9K transformants (histidine prototrophy and Geneticin-
resistance) and the number of copies integrated in the Pichia gen-
ome, are also at play, as we have not characterized these colonies
further.
Based on the number of transformants, as well as the relative
expression levels of colonies we found that pPIC9K linearized by
PmeI at the 50AOX1 locus was the best expression vector in our
hands and therefore employed for all subsequent transformation
reactions into P. pastoris. Consequently, we only examined Mut+
or MutS backgrounds on the effect of protein expression in the rest0
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Fig. 2. Effect of His phenotype on protein expression. (A) 48 colonies derived from transfo
trials. (B) 48 colonies derived from transformation reaction 3 (His phenotype) were test
analyzed by dot blot, and each signal was quantiﬁed as an integrated density percent oof this study by using either GS115 or KM71H pPIC9K-modiﬁed
strains.
Single colony screening reveals a difference of up to 20-fold in the yield
of MD variant protein secretion
First, the sensitivity and the speciﬁcity of anti-His-tag blots
were assessed as follows. Increasing amounts of puriﬁed His-
tagged protein (TEV protease) were blotted and a strong signal
was observed at a concentration of at least 1 mg/L, which repre-
sents approximately 50 nM for a 20 kDa His-tagged protein
(Supplementary Fig. 1). The absence of background signal was
checked by blotting culture supernatants of antibiotic-resistant
Pichia strains transformed with a mixture of PmeI-linearized non-
recombinant pPIC9K and pPICZa vectors and induced under the
same conditions as those used for MD protein expression (Supple-
mentary Fig. 2). These controls validate the use of Western and dot
blot in this study.
Next, a time course of expression was performed on a single col-
ony for each recombinant Pichia strain. Samples were taken at var-
ious time points throughout expression over a week and analyzed
by Western blotting in reducing conditions. Expression of all four
proteins appeared to plateau after 72 h in Mut+ GS115 (Fig. 3)
and after 96 h in MutS KM71H (not shown).
Then, 48 recombinant colonies were screened by dot blotting
for their relative expression levels for each MD protein at the opti-
mal time determined for each strain (72 h for GS115 and 96 h for
KM71H) (Fig. 4). Signiﬁcant variations in expression levels were
observed among colonies. Selection of the highest-expressing24                                               36                                                48     
y number
24                                               36                                                48     
 number
rmation reaction 1 (His+ phenotype) were tested for expression levels in small-scale
ed for expression levels in small-scale trials. The supernatant from each colony was
f the total signal using ImageJ.
20kDa
1       2       2.3     2.8      3      3.5      4      4.5 days 
1       2       2.3     2.8      3      3.5      4      4.5 days 
25kDa
37kDa
20kDa
25kDa
37kDa
250kDa
Fig. 3. Time course of expression. A typical time course of expression was
performed on a single colony for each recombinant Pichia strain. Samples were
taken at various time points throughout expression over a week and analyzed by
anti-His Western blot in reducing conditions. Supernatants (A) and cell lysates (B)
from GS115/hMD-2 cultures are represented here.
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much as 20-fold.Fig. 4. Single colony screening for the detection of the highest-expressing colony. 48 reco
in small-scale expression screens, and the relative expression level of each colony was co
variant in GS115 were analyzed, along with colonies 1–24 (C) and 25–48 (D) expressing t
was selected for all future expression studies, is circled. The MD variant shown here isOptimal culture conditions vary according to protein
In order to further improve the yield from Pichia expression, the
highest-expressing colony of each protein in each strain was sub-
jected to a small-scale screen of varying media conditions during
protein expression (Fig. 5). Culture supernatants from expression
in each condition were analyzed by dot blotting, followed by signal
quantiﬁcation. Because samples of equal volumes (5 ll) were ana-
lyzed without OD600nm readings for normalization, this assay can
only suggest trends in expression that are not quantitative. The
optimal media type appeared to vary according to protein,
although hMD-2 and HE82–89 exhibited overall similar behavior,
which is expected due to their nearly identical amino acid
sequences.
The effect of pH
The recombinant proteins used in this study cover a large range
of isoelectric points with hMD-2 being the most basic and hMD-1
the most acidic (pIhMD-2 = 8.34; pIHE82-89 = 8.15; pIeMD-2 = 7.23;
pIhMD-1 = 5.50). Therefore we decided to test BMMYmedia buffered
between pH 5.0 and 8.5 (Fig. 5A) as well as unbuffered minimal
medium MM, the pH of which drops below 3.0 during induction
(Fig. 5D and E). We found that the pH did impact the expression
levels of MD proteins. The observed trend suggests that the opti-
mal pH for expression in buffered complex media peaks around
each protein’s pI. Nevertheless protein expression levels were gen-
erally highest in unbuffered minimal media.
The effect of methanol
Although a daily addition of 0.5% methanol is recommended for
induction (Invitrogen manuals), some studies have optimal yieldsmbinant colonies of strain GS115 and KM71H expressing each variant were induced
mpared by anti-His dot blotting. Colonies 1–24 (A) and 25–48 (B) expressing an MD
he same MD variant in KM71H. The highest-expressing colony of each strain, which
HE82–89.
Fig. 5. Optimization of induction. The highest-expressing colony of each protein in each strain was expressed in 24 different culture conditions (see Supplementary Table 1 for
culture medium composition), on a small scale, and supernatants were analyzed by dot blotting followed by signal quantiﬁcation with ImageJ. The relative expression in each
condition is indicated by the integrated density percent of the total signal present for proteins expressed in Pichia strain GS115 (left panels) and KM71H (right panels). (A) Effect
of pH. Values between 5.0 and 8.0 have been tested in BMMY in one unit increments. (B) Effect of methanol. Daily addition of increasing concentrations (0.5%; 1.0%; 1.5%; 2.0%)
of methanol have been tested. (C) Effect of yeast extract and peptone. Complex BMMY and minimal buffered media in absence and in the presence of 1% glycerol, BMG and
BMM, respectively, have been compared here. (D) Effect of glucose. Increasing concentrations (0%; 0.1%; 0.2%; 0.5%) of glucose have been tested in either BMMY orMM for each
construct as indicated. (E) Effect of glycerol. Increasing concentrations (0%; 0.1%; 0.2%; 0.5%) of glycerol have been tested in either BMMY or MM on each construct.
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2% methanol were screened for their effect on expression (Fig. 5B).
In our hands, there was no obvious trend using higher methanol
concentrations, which was therefore kept at 0.5%. Although meth-
anol was supplemented daily initially, we subsequently opted for
addition every 12 h for a more sustained expression.The effect of culture media composition
We tested protein secretion into three different media BMMY,
BMG and BMM all buffered at pH 6.0 (Fig. 5C) with expression
induced by daily addition of 0.5% methanol. BMMY is a complex
medium and differs from minimal BMG and BMM media by its
content in yeast extract and peptone. BMG contains 1% glycerol,
which is thought to repress AOX1-driven gene expression. We
found that all four MD proteins shared the same feature of media
preferences and exhibited extremely reduced expression levels in
buffered minimal medium BMM.The effect of alternative carbon sources
Even though high concentrations of alternative carbon sources
including glycerol and glucose depresses the induction mechanism
via AOX1, small amounts of glycerol and glucose have been shown
to improve the yield from Pichia expression [19,20]. Given our pre-
vious result with BMG (Fig. 5C), 0.1%, 0.2%, 0.5% glucose (Fig. 5D)
and glycerol (Fig. 5E) were screened for their effect on yield as well.
Screening was performed in both minimal medium MM and buf-
fered complex medium BMMY pH 6.0, as there was no rationale
for expecting their effect on expression to be the same in both
media types. We observed that the presence of at least 0.1% of an
alternative carbon source, either glucose or glycerol, appeared to
increase expression levels.The effect of Mut phenotype
We comparedMut+ or MutS backgrounds on the effect of protein
expression by using either GS115 or KM71H pPIC9K-modiﬁed
strains. The only detectable strain-speciﬁc media preference was
an even larger increase in yield associated with the inclusion of
small amounts of glucose or glycerol in the medium of KM71H
expression cultures. The optimal expression conditions determined
for each strain were as follows: for hMD-2, minimal medium
MM + 0.2% glycerol for GS115 and MM + 0.1% glycerol for KM71H;
for HE82–89, we used BMMY at pH 7.0 for GS115 and MM + 0.2%
glycerol for KM71H; for eMD-2, it was MM + 0.1% glucose for
GS115 and BMMY + 0.2% glycerol for KM71H; for hMD-1, we chose
MM + 0.1% glycerol for GS115 and MM + 0.2% glycerol for KM71H.
This resulted in at least a 2-fold improvement of yield over standard
BMMY induction medium upon quantiﬁcation via large-scale
expression and puriﬁcation trials.MD-1 and MD-2 variants are produced as a heterogeneous collection
of oligomers
In contrast to the variation in the yield of protein production, no
colony-speciﬁc variation was observed in the oligomeric state of
MD-1 and MD-2 variants (data not shown). Nickel puriﬁed protein
was submitted to size-exclusion chromatography and eluted in the
void volume of the gel-ﬁltration column (Fig. 7). Non-reducing
SDS–PAGE revealed the presence of ‘‘monomers’’ and multimeric
species in the gel-ﬁltration peak fractions and suggested that
aggregation was mediated via both intermolecular disulﬁde bonds
and non-covalent protein–protein interactions.The effect of culture additives on MD proteins
Additives are traditionally assessed on proteins in solution for
their effect on folding and solubility. Some of them can be classi-
ﬁed as kosmotropes or chaotropes according to their effect on
the stability and the structure of water, which affects interactions
between solvent and proteins as well as protein–protein contacts.
These effects are described in the Hofmeister or lyotropic series.
Additives are not routinely tested in yeast cultures. Since aggrega-
tion seemed to occur during culture for MD proteins, we reasoned
that additives might have a stabilizing effect on the secreted pro-
teins. However, these agents may also affect Pichia growth, cell
metabolism, and protein biosynthesis kinetics if they are taken
up into the cells and used as nutrients or cofactors. The effect of
additives in cell cultures might therefore be direct or indirect
and affect a range of cellular processes including recombinant pro-
tein production.
A panel of 30 different anti-aggregation agents was selected for
inclusion in the induction culture medium (Supplementary Table
2). Small-scale screens were performed on each protein. The high-
est-expressing recombinant GS115 or KM71H colony was grown in
72 different conditions in 24-well plates containing different anti-
aggregation additives in the induction media. The effect of each
additive was tested in both buffered complex induction medium
as well as minimal induction medium, as the different pH and com-
position of these two media might have differential effects upon
the additives’ efﬁcacy. After 72 h (GS115) or 96 h of induction
(KM71H), supernatants were harvested and analyzed by dot blot
(Supplementary Fig. 3–6). From this initial analysis it appeared
that some additives were detrimental to the overall protein expres-
sion levels. These agents were excluded from any subsequent anal-
ysis. Others gave a strong signal on dot blot and were further
analyzed by Western blot under non-reducing conditions in order
to test their ability to prevent intermolecular disulﬁde bond forma-
tion (Supplementary Fig. 7–14). The best results are shown in Table
1 and Fig. 6.
The presence of magnesium sulfate in culture inhibits hMD-2 aggrega-
tion
Without the inclusion of an additive, a small almost undetect-
able proportion of MD-2 is expressed in its monomeric form
(Fig. 6). Overall, the yield of hMD-2 expression in both GS115
and KM71H strains beneﬁts from most detergents and kosmotrop-
ic agents, as well as chaotropic additives and the MD-2 binding li-
gand LPS. In particular, magnesium sulfate has a dramatic effect
upon expression of hMD-2 in GS115. Both magnesium sulfate
and magnesium chloride improve production in KM71H cells.
Magnesium salts do not only possess kosmotropic properties that
can beneﬁt protein folding and solubility they are also taken up
by cells and affect intracellular processes. Interestingly the effect
of magnesium salts is strongest in minimal induction medium, in
which nutrients and cofactors might be a limiting factor for proper
protein production. Several other additives with unrelated chemi-
cal properties appear to increase the expression of monomeric MD-
2 when expressed in KM71H, including NaSCN, NDSB-201, and LPS
itself.
The presence of ammonium sulfate in culture inhibits HE82–89
aggregation
Inclusion of additives in the culture medium also enriched the
HE82–89 population for its monomeric form. However, ammo-
nium sulfate, rather than magnesium sulfate, exhibited the most
dramatic effect in encouraging monomer formation. Ammonium
sulfate is both a kosmotropic agent and a nutrient that might alter
Table 1
Optimal additives for production of monomeric MD protein. A panel of anti-aggregation additives including kosmotropic agents, chaotropic agents, amino acids, ionic detergents,
non-ionic detergents, zwitterionic detergents, reducing agents, and others were selected (Supplementary Table 2). Each anti-aggregation additive was tested in small-scale
cultures both in buffered complex induction medium (BMMY) as well as minimal medium (MM), as the different pH and composition of these media inﬂuenced the effect of these
agents upon the inhibition of protein aggregation. First, each agent was tested for its ability to promote or not to interfere with secretion of MD proteins by dot blot analysis
(Supplementary Fig. 3-6). Then a subset of the additives that had given a strong expression signal was further characterized by Western blot analysis in non-reducing conditions
(Supplementary Fig. 7–14). The agents were evaluated for their potency to inhibit intercatenary disulﬁde bonding and optimal conditions are summarized here.
Proteins Pichia pastoris strains
GS115 KM71H
hMD-2 MM + 0.2M MgSO4;
MM + 1% FCS;
MM + 0.1M MgCl2;
MM + 0.2M MgSO4;
MM + 0.01mg/ml LPS;
BMMY + 0.01mg/ml LPS;
BMMY + 1% FCS;
BMMY + 0.1M NaSCN;
BMMY + 0.01mg/ml LPS;
BMMY + 0.5M NDSB-201;
HE82-89 WMVIII;
BMMY + 0.15M (NH4)2SO4; BMMY + 1.5% glycine;
BMMY + 0.15M (NH4)2SO4;
eMD-2 MM + 10% FCS; MM + 0.15M (NH4)2SO4;
BMMY + 0.01mg/ml LPS;
BMMY + 0.5M NDSB-201;
BMMY + 0.1M NaSCN;
BMMY + 0.5M KCl;
hMD-1 MM + 1% L-glutathione;
MM + 0.01mg/ml LPS;
BMMY + 0.01mg/ml LPS;
BMMY + 1.5% glycine;
BMMY + 0.5M NDSB-201;
BMMY + 0.01mg/ml LPS;
BMMY + 0.1M CaCl2;
BMMY + 0.1M MgCl2;
BMMY + 0.5M KCl.
Fig. 6. Effect of culture media additives on the prevention of intermolecular disulﬁde formation. A recombinant colony of each construct was induced in the absence of
culture additives () and in the presence of a given anti-aggregation agent at the following concentrations: 0.2 M MgSO4; 0.15 M (NH4)2SO4; 0.5 M NDSB-201; 1.5% glycine;
0.1 M NaSCN; 0.5 M KCl; 0.01 mg/ml LPS from E. coli O127:B8 (Sigma L3129). Samples of supernatants harvested from each construct were analyzed by Western blotting in
non-reducing conditions. (A) GS115 cultures and (B) KM71H cultures.
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on hMD-2, ammonium salts were only effective on the mutant pro-
tein in complex medium. As a slightly weaker kosmotropic agent
compared to magnesium sulfate, it would also weaken the entropic
cost of hydrating hydrophobic patches, reducing water structure in
the process. The preferred effect of ammonium sulfate in the caseof HE82–89 may reﬂect the subtle difference in amino acid
sequence between this mutant and hMD-2 and was observed in
both yeast strains. Out of the four MD proteins tested, HE82–89
depended the least on the presence of LPS for monomer production
as expected for a constitutively active protein. In contrast, the
effect of the amino acid additive glycine exhibited a particularly
Fig. 7. Inclusion of additives in culture medium and puriﬁcation buffers allows
isolation of monomeric protein. Typically, expression cultures were prepared, and
the harvested supernatant was concentrated and buffer-exchanged by tangential
ﬂow ﬁltration prior to protein puriﬁcation. After Nickel afﬁnity chromatography,
the sample was concentrated, and puriﬁed by gel ﬁltration on a HiLoad 16/60
Superdex 200 column. (A) In absence of additive proteins from an 8L-culture of
GS115–hMD-2 in BMMY medium eluted in the void volume only (blue chromato-
gram; aggregates eluted at 43.3 ml). Optimization of the culture medium
(MM + 0.2% glycerol instead of BMMY) and inclusion of 0.2 M MgSO4 signiﬁcantly
improved the yield of monomeric hMD-2 protein production (red chromatogram;
aggregates eluted at 42.9 ml and monomers at 96.8 ml). The nature of the second
peak was conﬁrmed by anti-His dot blotting. (B) Gel-ﬁltered proteins taken from
both peak fractions with elution proﬁles corresponding to aggregates and mono-
meric proteins were analyzed on a non-reducing Coomassie-stained SDS–PAGE gel.
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ing both the yield and proportion of monomers formed.
A non-detergent sulfobetaine for eMD-2
The additive, which caused the most dramatic inhibition of
intermolecular disulﬁde bond formation was the non-detergent
sulfobetaine NDSB-201 for eMD-2 (Fig. 6). This additive signiﬁ-
cantly increased the yield of expression as well as the relative pro-
portion of monomers in the total eMD-2 population. The weak
kosmotropic salts NaSCN and KCl also inhibited intermolecular
disulﬁde bond formation among eMD-2 species. Finally, LPS
appeared to enrich the eMD-2 population for its monomeric form
in buffered complex medium, but not in minimal medium, as ob-
served for both hMD-2 and hMD-1.
LPS, but not hMD-2, inhibits hMD-1 aggregation in culture
As seen for other MD proteins, expression of hMD-1 in the ab-
sence of additives resulted in a limited proportion of monomeric
hMD-1 in culture supernatant (Supplementary Fig. 13–14). How-
ever, this proportion was signiﬁcantly enhanced by additives such
as LPS, NDSB-201, the reducing agent L-oxidized glutathione, and
chloride-containing salts. It is often found that inclusion of a ligand
and/or coexpression of a physiological partner can stabilize a pro-
tein that would otherwise be unstable or unfolded. In order to test
this hypothesis, we compared hMD-1 expression and aggregation
levels in the presence or absence of LPS and hMD-2. Interestingly,
inclusion of LPS or fetal calf serum, but not hMD-2, partially pre-
vented aggregation in either strain GS115 or KM71H and only in
pH 6.0-buffered complex medium. Both hMD-1 and hMD-2 pro-
duced in KM71H strains appear to be more susceptible to the dis-
ruption of intermolecular disulﬁde bonds through anti-aggregation
agent interference. The amino acid glycine and the non-detergent
sulfobetaine NDSB-201 caused a dramatic enhancement in the pro-
portion of hMD-1 which does not form intermolecular disulﬁde
bonds, with glycine exhibiting a slightly stronger effect.Quantitative evaluation of the effect of additives
Whereas small-scale screening only allowed qualitative evalua-
tion of the effect of additives, large-scale preparations were
required for a quantitative assessment. Only the additives pre-
dicted to have the strongest effect on each protein were analyzed.
In order to estimate the effect of each additive, cultures were
grown in either complex or minimal medium with and without
additive. Secreted proteins were prepped in a two-step puriﬁcation
protocol described in Material and methods. Typically several liters
(up to 8 L) of expression cultures were prepared, and the harvested
supernatant was concentrated and buffer-exchanged by tangential
ﬂow ﬁltration prior to protein puriﬁcation. After Nickel afﬁnity
chromatography, the sample was concentrated, and submitted to
gel ﬁltration on a HiLoad 16/60 Superdex 200 column (Fig. 7). In
the absence of additives MD proteins eluted in the void volume.
Inclusion of the appropriate additive in the culture medium and
the puriﬁcation buffers signiﬁcantly improved the yield of mono-
meric protein production. The best result obtained with hMD-2
was in the presence of 0.2 MMgSO4 with the production of approx-
imately 15% monomeric protein out of 4 mg total protein subjected
to gel-ﬁltration.Discussion
It has been conclusively proven that monomeric MD-2 is the ac-
tive species responsible for LPS binding and TLR4 activation. How-
ever, the oligomeric form of secreted MD-2 has been reported in
multiple expression systems, including mammalian HEK293 and
HeLa cells [10,21–24]. It remains unknown whether this oligo-
meric form exists physiologically or whether it is an artifact of
overexpression. This study demonstrates another expression sys-
tem in which the disulﬁde-mediated oligomerization of MD-2 as
well as MD-1 proteins is observed. It is unclear how misfolded pro-
teins interlinked into high molecular weight oligomers escape the
quality control mechanisms which prevent improperly folded pro-
teins from leaving the ER. MD proteins may be properly folded in
the ER, passing through the quality control mechanisms normally,
and may oxidize and aggregate through covalent and non-covalent
interactions extracellularly. This hypothesis is plausible because
the secretory pathway provides chaperones and a protective envi-
ronment for newly folded proteins, whereas the extracellular med-
ium affords contact with oxidative molecules near the medium-air
interface, which may oxidize MD proteins and mediate aggrega-
tion. On the other hand, Western blotting in non-reducing condi-
tions in this study revealed the same array of oligomeric species
present in both the lysate and the supernatant of Pichia induction
cultures. Also, a previous study of intracellular Pichia expression
observed the same range of oligomeric species with a cytoplasmic
expression system [25]. Thus, aggregation and oligomerization
mediated by improper folding and disulﬁde bond formation may
occur as the protein is synthesized. This explanation is not implau-
sible, as misfolded MD proteins are known to be able to escape the
quality control mechanism in mammalian cells too: mutated MD-2
lacking all seven cysteine residues is secreted into the medium in
HEK293 [9]. Thus, MD-2 may form intermolecular disulﬁde bonds
and oligomeric aggregates early in its folding process, and may
evade quality control of Pichia by an unknown mechanism.
In this study, a novel method was developed which provides a
means of stabilizing secreted proteins and inhibiting improper
formation of intermolecular disulﬁde bonds during secreted pro-
tein expression. Due to the heterogeneity and instability of MD
proteins expressed in this system, this method was required to
isolate monomeric protein from Pichia culture supernatants. The
mechanism by which this novel method decreases aggregation
182 K.E. Mengwasser et al. / Protein Expression and Puriﬁcation 76 (2011) 173–183and the formation of intermolecular disulﬁde bonds is not
entirely straightforward. Pichia cells can absorb anti-aggregation
agents such as magnesium sulfate. The intracellular effects of
such an additive can then either be direct or indirect. Magnesium
sulfate could help solubilize newly synthesized proteins intracel-
lularly as well as extracellularly, but it could also affect protein
production as a nutrient and/or a cofactor affecting a variety of
processes including cellular metabolism, protein synthesis and
molecular transport. Alternatively, many of the anti-aggregation
agents probably stabilize secreted protein in the extracellular
milieu, preventing oxidation of misfolded species and aggregation
via hydrophobic and ionic interactions. In keeping with the effect
of additives in solution, we also found that pH affected protein
expression. pH can affect their solubility via its effect on charged
and polar surface residues that interact with ionic groups in the
solvent. A protein may precipitate out of solution in absence of
such ionic interactions. All MD proteins behaved well in the acidic
environment of unbuffered minimal medium, which can prevent
oxidation of free sulfhydryl side-chains. Surprisingly, the optimal
pH for expression in buffered complex medium peaked around
each protein’s pI. This is an unusual effect unless there is a dis-
crepancy between the theoretical pI and the real electrostatic
charge of the molecule. The tested kosmotropic and chaotropic
agents likely do not interact with the protein directly, but rather
affect the ordering of water molecules around the protein, raising
or lowering the entropic cost of hydrating its hydrophobic
regions. Nutrients and cofactors potentially alter cell metabolism
and protein synthesis kinetics. This effect was generally more
pronounced in minimal medium, compared to complex medium,
in which these components might be found in limited amounts.
The detergents tested may interact with the protein, in particular
at the exposed hydrophobic regions and at the site of LPS binding.
The mild reducing agents tested likely stabilize the free sulhydryl
groups and prevent their oxidation in the extracellular medium.
The ligand tested most likely exerts its stabilizing effect through
direct binding.
Regardless of the mechanism of action at play, this novel meth-
od for inhibiting protein aggregation may be relevant for the prep-
aration of any secreted glycoprotein, which exhibits similar
instability. There is some precedent for the unusual tendency to
aggregate by intermolecular disulﬁde bond formation in culture
supernatants. For example, secreted meprin A metalloproteinase
produced in HEK293 cells forms higher-order molecular weight
oligomers when secreted into the medium [26]. Similarly, Norrie
disease protein (Norrin) forms disulﬁde-linked oligomers when ex-
pressed by mammalian COS-7 cells [27]. A common feature of all
proteins, which exhibit this unusual behavior upon secretion is
the presence of N-linked glycosylation sites. Interestingly, one
group has found that mutation of the N-linked glycosylation sites
of meprin A metalloproteinase abolished inter-subunit disulﬁde
bond formation [28]. Glycosylation affects protein properties such
as solubility and folding, and thus it would be interesting to ana-
lyze if mutation of the N-linked glycosylation sites of MD-2, which
has been conducted in previous studies, might reduce the inter-
subunit disulﬁde bond formation among MD-2 species in various
expression systems.
Finally the effect of LPS on the production of monomeric MD-1
is surprising as MD-1 was long thought not to bind LPS [29]. The
solubilizing effect of LPS can only be explained by an interaction
with MD-1, since LPS itself possesses no kosmotropic or chaotropic
properties which might affect the oligomeric state of the protein.
During the editing of this manuscript, two crystal structures of
MD-1 have been published elsewhere [30,31]. These studies on
mouse and chicken MD-1 were supplemented with biochemical
analysis that also supports LPS binding. The functional importance
of MD-1 needs to be reassessed in the light of these recent ﬁndings.However, this property allows it to play an active role in modulat-
ing bacterial infection and LPS signaling.
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